Therapy of infection in patients with granulocytopenia.
D000380:Agranulocytosis / Q000150:complications*; D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001803:Blood Transfusion; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005839:Gentamicins / Q000627:therapeutic use; D006098:Granulocytes / Q000637:transplantation; D006801:Humans; D007239:Infections / Q000150:complications / Q000628:therapy*; D007668:Kidney / Q000187:drug effects; D007958:Leukocyte Count; D009181:Mycoses / Q000188:drug therapy; D009369:Neoplasms / Q000150:complications*; D011552:Pseudomonas Infections / Q000188:drug therapy; D013982:Ticarcillin / Q000627:therapeutic use; D014031:Tobramycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D000583:Amikacin; D013982:Ticarcillin; D002228:Carbenicillin; D002512:Cephalothin; D014031:Tobramycin